Philip Angell-Manning

Director Of Chemistry, Manufacturing & Controls (cmc) at Psioxus Therapeutics

Philip Angell-Manning is an experienced professional in the fields of chemistry, manufacturing, and controls, currently serving as the Director of Chemistry, Manufacturing & Controls at Akamis Bio. Previous roles include Director of Manufacturing and Process Development Manager at the University of Oxford's Jenner Institute Clinical BioManufacturing Facility, as well as Production Manager for both Glysure Ltd (Medical Devices) and Oxford BioMedica (Gene Therapy). Philip has also held positions as In-House Manufacturing Manager and Senior Scientist at Oxford BioMedica, alongside a Technician role in GMP Production of Coagulation Factors at Bio Products Laboratory Limited. Education includes degrees from The University of Manchester and The University of Salford.

Location

Oxford, United Kingdom

Links

Previous companies


Org chart


Teams


Offices


Psioxus Therapeutics

Psioxus Therapeutics is a cancer gene therapy company delivers medicines of value to patients with cancer.


Employees

51-200

Links